Financial Management Professionals’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.69K | Sell |
60
-10
| -14% | -$782 | ﹤0.01% | 634 |
|
2025
Q1 | $5.07K | Buy |
70
+63
| +900% | +$4.57K | ﹤0.01% | 634 |
|
2024
Q4 | $518 | Hold |
7
| – | – | ﹤0.01% | 885 |
|
2024
Q3 | $0 | Sell |
7
-38
| -84% | – | ﹤0.01% | 956 |
|
2024
Q2 | $4K | Sell |
45
-37
| -45% | -$3.29K | ﹤0.01% | 611 |
|
2024
Q1 | $8K | Buy |
82
+28
| +52% | +$2.73K | ﹤0.01% | 576 |
|
2023
Q4 | $4K | Hold |
54
| – | – | ﹤0.01% | 672 |
|
2023
Q3 | $4K | Sell |
54
-182
| -77% | -$13.5K | ﹤0.01% | 624 |
|
2023
Q2 | $22K | Sell |
236
-50
| -17% | -$4.66K | ﹤0.01% | 382 |
|
2023
Q1 | $24K | Buy |
286
+152
| +113% | +$12.8K | ﹤0.01% | 388 |
|
2022
Q4 | $10K | Buy |
134
+29
| +28% | +$2.16K | ﹤0.01% | 502 |
|
2022
Q3 | $9K | Buy |
105
+38
| +57% | +$3.26K | ﹤0.01% | 502 |
|
2022
Q2 | $6K | Sell |
67
-11
| -14% | -$985 | ﹤0.01% | 586 |
|
2022
Q1 | $9K | Sell |
78
-20
| -20% | -$2.31K | ﹤0.01% | 544 |
|
2021
Q4 | $13K | Buy |
98
+12
| +14% | +$1.59K | ﹤0.01% | 433 |
|
2021
Q3 | $10K | Buy |
86
+32
| +59% | +$3.72K | ﹤0.01% | 474 |
|
2021
Q2 | $6K | Buy |
+54
| New | +$6K | ﹤0.01% | 482 |
|